Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Aortic Stent Grafts are used to reinforce a weakened aorta to prevent ruptures. GlobalData uses proprietary data and analytics to provide a comprehensive report on the aortic stent grafts devices market, including market shares of different players within Switzerland. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the aortic stent grafts market in Switzerland was W. L. Gore & Associates followed by Medtronic, Cook Medical, Terumo, Artivion, Cordis and Shanghai MicroPort Endovascular MedTech Group.
Aortic Stent Grafts are made of allografts or synthetic materials. Aortic Stent Grafts include Abdominal Aortic Stent Grafts and Thoracic Aortic Stent Grafts along with additional extensions. Abdominal Aortic Stent Grafts are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a minimally invasive interventions. Thoracic Aortic Stent Grafts are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive interventions. Extension pieces are additional pieces that are used in conjunction with the stent graft to extend the length of the stent graft.
The value of the aortic stent grafts devices market within Switzerland was expected to be over $10m in 2023.
For the latest complete market share analysis of aortic stent grafts device market in Switzerland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
